Large-scale testing (Phase 3)Ended earlyNCT00463723
What this trial is testing
Topical FK506 (Tacrolimus) for Prevention of Immune Reactions Following Penetrating Keratoplasty
Who this might be right for
Penetrating Keratoplasty
University Hospital Freiburg